ICU Medical price target lowered to $173 from $191 at KeyBanc

KeyBanc analyst Brett Fishbin lowered the firm’s price target on ICU Medical (ICUI) to $173 from $191 to reflect lower industry/peer multiples, while keeping an Overweight rating on the shares. The firm remains encouraged by ICU’s significant progress in demonstrating increased operational and financial stability.